510(k) Report

510(k) · Cleared

Cleared

NEBA® Compact EEG2R Mobile Headset

K223628510(k) TraditionalCleared Mar 2, 202387-day reviewClass II21 CFR 882.1400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Neba Health, LLC · OMC Reduced- Montage Standard Electroencephalograph

Cleared on Mar 2, 2023 as substantially equivalent to K203827 (Epitel, Inc., 2021) and 1 other predicate after an 87-day review. Its family tree reaches back 4 generations to 1983.

Decided
Mar 2, 2023
Review
87 days
Class
Class II
Product code
OMC
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K830295 (1983). 6 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK830295 Medilog 9000 SystemOxford Medilog, Inc. · 1983
  2. 3 generations backK170363 Ceribell Pocket EEG DeviceCeribell, Inc. · 2017
  3. 2 generations backK183529 AE-120A EEG Head SetNihon Kohden Corporation · 2019
  4. 1 generation backK203827 REMIEpitel, Inc. · 2021
  5. This deviceK223628 NEBA® Compact EEG2R Mobile HeadsetNeba Health, LLC · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K830295Medilog 9000 SystemOxford Medilog, Inc.1983—
−3K170363Ceribell Pocket EEG DeviceCeribell, Inc.2017—
−2K183529AE-120A EEG Head SetNihon Kohden Corporation2019—
−1K203827REMIEpitel, Inc.2021—
0 (this device)K223628NEBA® Compact EEG2R Mobile HeadsetNeba Health, LLC2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
201010
201710
FIG. 1 — Lineage of K223628, 1983–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OMC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OMC device

  1. #1 K251550 NX01 (NX01)score 13.1 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K203827REMI
Summary page 4
…rology; Diagnostic Devices Predicate and reference devices Predicate Type 510K Number Device Manufacturer Primary Predicate K203827 REMI Epitel, Inc. Secondary Predicate K183529 AE-120A EEG Headset Nihon Kohden…
Epitel, Inc.2021—
*K183529AE-120A EEG Head Set
Summary page 4
…510K Number Device Manufacturer Primary Predicate K203827 REMI Epitel, Inc. Secondary Predicate K183529 AE-120A EEG Headset Nihon Kohden…
Nihon Kohden Corporation2019—

Also cleared against K203827: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 40 years and passes through 5 companies; a new generation was cleared every 2.0 years on median.
  • None of the 6 ancestors has a recall.
  • 1 other device also cites its predicate K203827.

How does its category compare?

All OMC devices

OMC Reduced- Montage Standard Electroencephalograph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · OMC

3in 2025

2010: 12011: 12012: 12013: 12014: 12015: 12017: 12019: 12020: 12021: 12022: 12023: 22024: 32025: 32026 (partial year): 1
2007high 3 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OMC

172in 2025

2024: 56 days median2025: 172 days median
2007high 172 (2025) · low 56 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OMC

No recall names OMC since 2007.

Adverse event reports per year · OMC

2in 2025

2023: 22024: 22025: 2
2007high 2 (2023) · low 0 (2007)2025

MAUDE reports naming product code OMC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20101—00
20111—00
20121—00
20131—00
20141—00
20151—00
20160—00
20171—00
20180—00
20191—00
20201—00
20211—00
20221—00
20232—02
202435602
2025317202
20261—0—

What is it indicated for?

The NEBA® Compact EEG 2R Mobile Headset (NEBA Headset) is intended to capture, amplify, and wirelessly transmit electrical brain activity for review by a trained medical professional using the CEEG2R recording software. The NEBA Headset comprises an electrode positioning system for placing single-use disposable electrodes on the head (Vermed® A10005, ANSI/AAMI EC12 compliant silver/silver-chloride (Ag/AgCl) electrodes). Contained within the headset is a…

Read the full statement (166 words)

The NEBA® Compact EEG 2R Mobile Headset (NEBA Headset) is intended to capture, amplify, and wirelessly transmit electrical brain activity for review by a trained medical professional using the CEEG2R recording software.

The NEBA Headset comprises an electrode positioning system for placing single-use disposable electrodes on the head (Vermed® A10005, ANSI/AAMI EC12 compliant silver/silver-chloride (Ag/AgCl) electrodes).

Contained within the headset is a wireless EEG amplifier module.

The NEBA Headset and its associated software do not provide any diagnostic conclusion or automated alerts of any clinical event about a patient's condition.

The NEBA Headset transmits electrophysiological signals from the electrodes to a CEEG 2R IEC/UL 60950-1 safety compliant computer running the NEBA CEEG 2R recording software.

The system supports six electrode locations (CZ, left ocular, right ocular, left ear, right ear, and ground) on four flat flexible leads and one plastic tab (the latter to support the CZ electrode).

The CEEG2 Headset is intended for use in clinical settings in individuals six years of age and older.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K223628: NEBA® Compact EEG2R Mobile Headset.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K223628

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026